Physician profile
Omer Iftikhar
NPI 1861832073
$22,155.79
in general payments reported to CMS, 2019-2025
32 companies · $2,917 in 2025
The $2,917 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,006 · 2020: $3,162 · 2021: $649 · 2022: $9,039 · 2023: $3,099 · 2024: $2,283 · 2025: $2,917.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,323 · Travel and Lodging: $3,976.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,323.29 |
| Travel and Lodging | $3,975.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $4,325.31 | 2021-2025 | Indigo System |
| Medtronic, INC. | $4,171.14 | 2021-2025 | Corevalve Evolut R, Micra, Linq II |
| Boston Scientific Corporation | $3,388.49 | 2019-2025 | Versacross Access Solution, Watchman Flx, General - Structural Heart |
| Edwards Lifesciences Corporation | $2,135.84 | 2022-2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Medtronic Vascular, INC. | $2,034.69 | 2019-2020 | |
| Abbott Laboratories | $1,735.94 | 2020-2025 | Cardiomems, Esprit, Diamondback Coronary |
| W. L. Gore & Associates, INC. | $932.91 | 2022 | |
| Inari Medical, INC. | $303.84 | 2022-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Amgen INC. | $286.83 | 2022-2025 | Repatha, Repatha |
| Shockwave Medical, INC | $272.15 | 2020-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cardiovascular Systems INC. | $258.41 | 2020-2022 | |
| Endologix LLC | $257.24 | 2025 | Torus Stent Graft System, Endocross Device |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $249.32 | 2023-2025 | Lifevest |
| Philips North America LLC | $244.87 | 2022-2025 | Eagle Eye, Labosys |
| E.R. Squibb & Sons, L.L.C. | $174.67 | 2024-2025 | Camzyos, Eliquis |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $164.45 | 2025 | Flowtriever, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Kestra Medical Technology Services, INC. | $139.37 | 2022-2025 | Assure Wcd |
| Baxter Healthcare | $129.27 | 2023-2024 | Hillrom - Carnation Ambulatory Monitor |
| Novartis Pharmaceuticals Corporation | $102.02 | 2022-2024 | |
| Irhythm Technologies, INC. | $94.10 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Biotronik INC. | $84.22 | 2022-2025 | Amvia Edge |
| Merck Sharp & Dohme LLC | $57.06 | 2021-2025 | Verquvo |
| Novo Nordisk INC | $52.91 | 2023 | Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $40.31 | 2023-2024 | Jardiance |
| Esperion Therapeutics, INC. | $38.79 | 2023-2025 | Nexletol |
| Kiniksa Pharmaceuticals International, Plc | $36.27 | 2024 | Arcalyst |
| Acist Medical Systems, INC. | $33.57 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $26.52 | 2025 | Opsynvi |
| Sanofi-Aventis U.S. LLC | $20.61 | 2023 | |
| Surmodics, INC. | $18.00 | 2025 | Pounce Thrombectomy, Pounce Venous Thrombectomy System, Sublime Microcatheter, 018, 200cm, Straight |
| Janssen Pharmaceuticals, INC | $16.62 | 2022 | |
| Ethicon US, LLC | $13.25 | 2024 | Zip Pen, Megadyne |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omer Iftikhar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.